Search

Your search keyword '"Engebråten, Olav"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Engebråten, Olav" Remove constraint Author: "Engebråten, Olav"
110 results on '"Engebråten, Olav"'

Search Results

1. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

2. Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes

3. The impact of coding germline variants on contralateral breast cancer risk and survival

5. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

6. Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes.

7. Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

8. MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients

9. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

10. The impact of coding germline variants on contralateral breast cancer risk and survival

11. Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer

13. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

14. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer

15. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer

16. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

18. Rare germline copy number variants (CNVs) and breast cancer risk

21. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

22. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

23. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

25. Subtype and cell type specific expression of lncRNAs provide insight into breast cancer.

26. Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft

27. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

29. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

31. Breast cancer quantitative proteome and proteogenomic landscape

32. Personalized Computer Simulations of Breast Cancer Tumors Treated with Neoadjuvant Chemotherapy and Bevacizumab

33. Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions.

34. DNA copy number motifs are strong and independent predictors of survival in breast cancer.

35. Abstract 114: Basal-like breast cancer engages tumor-supportive macrophages via cytokines triggered by extracellular S100A4

36. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

38. In vivo 31P MRSI for metabolic profiling of human breast cancer xenografts

39. Abstract LB-337: Systemic shift in genomic aberrations in breast carcinomas during neoadjuvant chemotherapy in combination with bevacizumab

40. Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer

41. Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

42. Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4.

43. pH-Responsive Nano Carriers for Doxorubicin Delivery

44. Abstract 1533: A time course study of genomic instability in breast cancer patients receiving neoadjuvant therapy with or without bevacizumab

Catalog

Books, media, physical & digital resources